Literature DB >> 21254239

Prognosis of periodontitis recurrence after intensive periodontal treatment using examination of serum IgG antibody titer against periodontal bacteria.

Noriko Sugi1, Koji Naruishi, Chieko Kudo, Aya Hisaeda-Kako, Takayuki Kono, Hiroshi Maeda, Shogo Takashiba.   

Abstract

Chronic periodontitis is associated with systemic diseases such as atherosclerosis. In this study, we evaluated the efficacy of serum IgG antibody titer to periodontal bacteria for prognosis of periodontitis recurrence during supportive periodontal therapy (SPT) phase. The 139 patients during SPT phase were selected and divided to two groups as follows: "Stable" and "Recurrence" group at SPT phase for case-control study: "High IgG titer" and "Normal IgG titer" group before transition to SPT phase for cohort study. We examined whether clinical findings or serum IgG antibody titers to periodontal bacteria are risk factors for the development of periodontitis recurrence. Case-control study showed that there were significant differences between the stable and recurrence groups in age and number of teeth. The serum IgG antibody titer to Eikenella corrodens FDC1073, Porphyromonas gingivalis SU63, and Campylobacter rectus ATCC33238 was significantly higher in the recurrence group. Next, we found, that the recurrence ratio in the high IgG titer group to Gram-negative obligate anaerobe, Prevotella intermedia, Treponema denticola, and C. rectus was significantly higher than that of the normal IgG titer group. Taken together, serum IgG antibody titer test is useful in the prognosis of periodontitis recurrence during the SPT phase.
© 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21254239      PMCID: PMC6647643          DOI: 10.1002/jcla.20381

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  21 in total

Review 1.  Supportive periodontal therapy.

Authors:  Stefan Renvert; G Rutger Persson
Journal:  Periodontol 2000       Date:  2004       Impact factor: 7.589

2.  Immunoglobulin G response of periodontitis patients to Porphyromonas gingivalis capsular carbohydrate and lipopolysaccharide antigens.

Authors:  T J Sims; R E Schifferle; R W Ali; N Skaug; R C Page
Journal:  Oral Microbiol Immunol       Date:  2001-08

3.  Plaque removal with variable instrumentation.

Authors:  L Checchi; G Forteleoni; G A Pelliccioni; G Loriga
Journal:  J Clin Periodontol       Date:  1997-10       Impact factor: 8.728

Review 4.  Low-grade inflammation in chronic infectious diseases: paradigm of periodontal infections.

Authors:  Niki M Moutsopoulos; Phoebus N Madianos
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

5.  Periodontal treatment improves endothelial dysfunction in patients with severe periodontitis.

Authors:  Gerald Seinost; Gernot Wimmer; Martina Skerget; Erik Thaller; Marianne Brodmann; Robert Gasser; Rudolf O Bratschko; Ernst Pilger
Journal:  Am Heart J       Date:  2005-06       Impact factor: 4.749

Review 6.  Effect of genetic variability on the inflammatory response to periodontal infection.

Authors:  Lior Shapira; Asaf Wilensky; Denis F Kinane
Journal:  J Clin Periodontol       Date:  2005       Impact factor: 8.728

7.  Infectious complications of dental and periodontal diseases in the elderly population.

Authors:  Kenneth Shay
Journal:  Clin Infect Dis       Date:  2002-04-02       Impact factor: 9.079

8.  Antibody responses against Porphyromonas gingivalis infection in patients with early-onset periodontitis.

Authors:  S Guo; K Takahashi; S Kokeguchi; S Takashiba; D F Kinane; Y Murayama
Journal:  J Clin Periodontol       Date:  2000-10       Impact factor: 8.728

Review 9.  Infection, its treatment and the risk for stroke.

Authors:  Frederick Palm; Christian Urbanek; Armin Grau
Journal:  Curr Vasc Pharmacol       Date:  2009-04       Impact factor: 2.719

10.  Serum IgG antibody response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis: implications for periodontal diagnosis.

Authors:  I B Lamster; I Kaluszhner-Shapira; M Herrera-Abreu; R Sinha; J T Grbic
Journal:  J Clin Periodontol       Date:  1998-06       Impact factor: 8.728

View more
  4 in total

1.  Serum immunoglobulin G antibody titer to Fusobacterium nucleatum is associated with unfavorable outcome after stroke.

Authors:  H Nishi; N Hosomi; K Ohta; S Aoki; M Nakamori; T Nezu; H Shigeishi; T Shintani; T Obayashi; K Ishikawa; N Kinoshita; Y Shiga; M Sugiyama; H Ohge; H Maruyama; H Kawaguchi; H Kurihara
Journal:  Clin Exp Immunol       Date:  2020-03-24       Impact factor: 4.330

2.  Assessing the progression of chronic periodontitis using subgingival pathogen levels: a 24-month prospective multicenter cohort study.

Authors:  E Kakuta; Y Nomura; T Morozumi; T Nakagawa; T Nakamura; K Noguchi; A Yoshimura; Y Hara; O Fujise; F Nishimura; T Kono; M Umeda; M Fukuda; T Noguchi; N Yoshinari; C Fukaya; S Sekino; Y Numabe; N Sugano; K Ito; H Kobayashi; Y Izumi; H Takai; Y Ogata; S Takano; M Minabe; A Makino-Oi; A Saito; Y Abe; S Sato; F Suzuki; K Takahashi; T Sugaya; M Kawanami; N Hanada; S Takashiba; H Yoshie
Journal:  BMC Oral Health       Date:  2017-01-16       Impact factor: 2.757

3.  The risk reduction of recurrent periodontal pathogens of local application minocycline HCl 2% gel, used as an adjunct to scaling and root planing for chronic periodontitis treatment.

Authors:  Y Soeroso; T Akase; H Sunarto; Y Kemal; R Salim; M Octavia; A Viandita; J Setiawan; B M Bachtiar
Journal:  Ther Clin Risk Manag       Date:  2017-03-10       Impact factor: 2.423

4.  Relationship between periodontitis-related antibody and frequent exacerbations in chronic obstructive pulmonary disease.

Authors:  Tamaki Takahashi; Shigeo Muro; Naoya Tanabe; Kunihiko Terada; Hirofumi Kiyokawa; Susumu Sato; Yuma Hoshino; Emiko Ogawa; Kazuko Uno; Koji Naruishi; Shogo Takashiba; Michiaki Mishima
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.